Articles:

Ceramide and the induction of apoptosis

WD Jarvis, S Grant, and RN Kolesnick
Clin Cancer Res 1996 2: 1 [PDF]  

Flow cytometric assay of modulation of P-glycoprotein function in whole blood by the multidrug resistance inhibitor GG918

SM Witherspoon, DL Emerson, BM Kerr, TL Lloyd, WS Dalton, and PS Wissel
Clin Cancer Res 1996 2: 7 [Abstract] [PDF]  

Radiolocalization of squamous lung carcinoma with 131I-labeled epidermal growth factor

A Cuartero-Plaza, E Martinez-Miralles, R Rosell, C Vadell-Nadal, M Farre, and FX Real
Clin Cancer Res 1996 2: 13 [Abstract] [PDF]  

Newcastle disease virus-infected intact autologous tumor cell vaccine for adjuvant active specific immunotherapy of resected colorectal carcinoma

D Ockert, V Schirrmacher, N Beck, E Stoelben, T Ahlert, J Flechtenmacher, E Hagmuller, R Buchcik, M Nagel, and HD Saeger
Clin Cancer Res 1996 2: 21 [Abstract] [PDF]  

Eastern cooperative group trial of interferon gamma in metastatic melanoma: an innovative study design

JH Schiller, M Pugh, JM Kirkwood, D Karp, M Larson, and E Borden
Clin Cancer Res 1996 2: 29 [Abstract] [PDF]  

Phase I trial of sulindac plus 5-fluorouracil and levamisole: potential adjuvant therapy for colon carcinoma

FA Sinicrope, R Pazdur, and B Levin
Clin Cancer Res 1996 2: 37 [Abstract] [PDF]  

Limited sampling model for area under the concentration time curve of total topotecan

H Minami, JH Beijnen, J Verweij, and MJ Ratain
Clin Cancer Res 1996 2: 43 [Abstract] [PDF]  

Virus-free transfer of the herpes simplex virus thymidine kinase gene followed by ganciclovir treatment induces tumor cell death

V Calvez, O Rixe, P Wang, R Mouawad, C Soubrane, A Ghoumari, O Verola, D Khayat, and F Colbere-Garapin
Clin Cancer Res 1996 2: 47 [Abstract] [PDF]  

Radiosensitization by 5-fluorocytosine of human colorectal carcinoma cells in culture transduced with cytosine deaminase gene

MS Khil, JH Kim, CA Mullen, SH Kim, and SO Freytag
Clin Cancer Res 1996 2: 53 [Abstract] [PDF]  

Gene modification of primary tumor cells for active immunotherapy of human breast and ovarian cancer

R Philip, B Clary, E Brunette, L Kilinski, D Murugesh, M Sorich, J Yau, J Lebkowski, HK Lyerly, and M Philip
Clin Cancer Res 1996 2: 59 [Abstract] [PDF]  

A case for the use of aminopterin in treatment of patients with leukemia based on metabolic studies of blasts in vitro

A Smith, M Hum, NJ Winick, and BA Kamen
Clin Cancer Res 1996 2: 69 [Abstract] [PDF]  

Activity of anti-erbB-2 recombinant toxin OLX-209 on lung cancer cell lines in the absence of erbB-2 gene amplification

PG Kasprzyk, TL Sullivan, JD Hunt, CT Gubish, CA Scoppa, M Oelkuct, R Bird, PH Fischer, JM Siegfried, and CR King
Clin Cancer Res 1996 2: 75 [Abstract] [PDF]  

Breast cancer cells are effectively purged from peripheral blood progenitor cells with an immunomagnetic technique

CL Tyer, JJ Vredenburgh, M Heimer, WP Peters, and RC Bast, Jr
Clin Cancer Res 1996 2: 81 [Abstract] [PDF]  

Detection of naturally processed and HLA-A1-presented melanoma T-cell epitopes defined by CD8(+) T-cells' release of granulocyte-macrophage colony-stimulating factor but not by cytolysis

MJ Maeurer, D Martin, E Elder, WJ Storkus, and MT Lotze
Clin Cancer Res 1996 2: 87 [Abstract] [PDF]  

Cytokeratin expression results in a drug-resistant phenotype to six different chemotherapeutic agents

JM Anderson, LM Heindl, PA Bauman, CW Ludi, WS Dalton, and AE Cress
Clin Cancer Res 1996 2: 97 [Abstract] [PDF]  

Evaluation of irinotecan in combination with 5-fluorouracil or etoposide in xenograft models of colon adenocarcinoma and rhabdomyosarcoma

JA Houghton, PJ Cheshire, JD Hallman, 2nd, L Lutz, X Luo, Y Li, and PJ Houghton
Clin Cancer Res 1996 2: 107 [Abstract] [PDF]  

Block of c-myc expression by antisense oligonucleotides inhibits proliferation of human thyroid carcinoma cell lines

J Cerutti, F Trapasso, C Battaglia, L Zhang, ML Martelli, R Visconti, MT Berlingieri, JA Fagin, M Santoro, and A Fusco
Clin Cancer Res 1996 2: 119 [Abstract] [PDF]  

Growth stimulation of human head and neck squamous cell carcinoma cell lines by interleukin 4

JN Myers, S Yasumura, Y Suminami, H Hirabayashi, Wc Lin, JT Johnson, MT Lotze, and TL Whiteside
Clin Cancer Res 1996 2: 127 [Abstract] [PDF]  

Aneusomies of chromosomes 8 and Y detected by fluorescence in situ hybridization are prognostic markers for pathological stage C (pt3N0M0) prostate carcinoma

S Takahashi, A Alcaraz, JA Brown, TJ Borell, JF Herath, EJ Bergstralh, MM Lieber, and RB Jenkins
Clin Cancer Res 1996 2: 137 [Abstract] [PDF]  

Prognostic significance of tumor cell proliferation rate as determined by the MIB-1 antibody in breast carcinoma: its relationship with vimentin and p53 protein

W Domagala, M Markiewski, B Harezga, A Dukowicz, and M Osborn
Clin Cancer Res 1996 2: 147 [Abstract] [PDF]  

p53 protein in non-small cell lung cancer as quantitated by enzyme-linked immunosorbent assay: relation to prognosis

H Pappot, D Francis, N Brunner, J Grondahl-Hansen, and K Osterlind
Clin Cancer Res 1996 2: 155 [Abstract] [PDF]  

Alterations in expression and function of signal-transducing proteins in tumor-associated T and natural killer cells in patients with ovarian carcinoma

P Lai, H Rabinowich, PA Crowley-Nowick, MC Bell, G Mantovani, and TL Whiteside
Clin Cancer Res 1996 2: 161 [Abstract] [PDF]  

Cyclin D1 gene amplification in human laryngeal squamous cell carcinomas: prognostic significance and clinical implications

A Bellacosa, G Almadori, S Cavallo, G Cadoni, J Galli, G Ferrandina, G Scambia, and G Neri
Clin Cancer Res 1996 2: 175 [Abstract] [PDF]  

Plasma levels of beta-carotene, lycopene, canthaxanthin, retinol, and alpha- and tau-tocopherol in cervical intraepithelial neoplasia and cancer

PR Palan, MS Mikhail, GL Goldberg, J Basu, CD Runowicz, and SL Romney
Clin Cancer Res 1996 2: 181 [Abstract] [PDF]  

Biological and molecular analysis of a low-grade recurrence of a glioblastoma multiforme

AC Scheck, JR Shapiro, SW Coons, SA Norman, and PC Johnson
Clin Cancer Res 1996 2: 187 [Abstract] [PDF]  

Cyclic adenosine 3',5'-monophosphate-binding proteins in human ovarian cancer: correlations with clinicopathological features

BJ Simpson, AD Ramage, MJ Hulme, DJ Burns, D Katsaros, SP Langdon, and WR Miller
Clin Cancer Res 1996 2: 201 [Abstract] [PDF]  

Differential sensitivity to non-major histocompatibility complex-restricted recombinant interleukin 2-activated lymphocyte killing of human mammary epithelial MCF-10A cells overexpressing oncogenes or protein kinase A subunits

P Tagliaferri, G Tortora, R Guarrasi, V Damiano, A Ruggiero, D Morelli, M Caraglia, R Bianco, G di Isernia, S Pepe, CL Arteaga, BC Langton-Webster, AR Bianco, and F Ciardiello
Clin Cancer Res 1996 2: 207 [Abstract] [PDF]  

Interleukin 6 acts as a paracrine growth factor in human mammary carcinoma cell lines

JJ Chiu, MK Sgagias, and KH Cowan
Clin Cancer Res 1996 2: 215 [Abstract] [PDF]  

Endometrial carcinoma and tamoxifen: clearing up a controversy

M Andersson, HH Storm, and HT Mouridsen
Clin Cancer Res 1996 2: 223 [PDF]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.